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von Willebrand factor A domainVWA domains are the predominant independent folding units within matrilins and mediate protein–pro-
tein interactions. Mutations in the matrilin-3 VWA domain cause various skeletal diseases. The analysis
of the pathological mechanisms is hampered by the lack of detailed structural information on matrilin
VWA domains. Attempts to resolve their structures were hindered by low solubility and a tendency to
aggregation. We therefore took a comprehensive approach to improve the recombinant expression of
functional matrilin VWA domains to enable X-ray crystallography and nuclear magnetic resonance
(NMR) studies. The focus was on expression in Escherichia coli, as this allows incorporation of isotope-
labeled amino acids, and on ﬁnding conditions that enhance solubility. Indeed, circular dichroism (CD)
and NMR measurements indicated a proper folding of the bacterially expressed domains and, interest-
ingly, expression of zebraﬁsh matrilin VWA domains and addition of N-ethylmaleimide yielded the most
stable proteins. However, such proteins did still not crystallize and allowed only partial peak assignment
in NMR. Moreover, bacterially expressed matrilin VWA domains differ in their solubility and functional
properties from the same domains expressed in eukaryotic cells. Structural studies of matrilin VWA
domains will depend on the use of eukaryotic expression systems.
 2014 Published by Elsevier Inc.Introduction
The matrilins form a four-member family of extracellular
matrix proteins and belong to the superfamily of von Willebrand
factor A (VWA)1-containing proteins. Matrilins are expressed in car-
tilage and many other forms of extracellular matrix, where they are
part of ﬁbrillar or ﬁlamentous structures and mediate interactions
between collagen-containing ﬁbrils and other matrix components.
They are modular, multi-subunit proteins with most subunits con-
sisting of two VWA-domains interconnected by a variable number
of epidermal growth factor (EGF)-like domains (for review see [1]).
Only matrilin-3 lacks the second VWA-domain. The C-terminala-helical coiled-coil-domain enables the oligomerisation of single
subunits to trimers (matrilin-1 and -4) and tetramers (matrilin-2
and -3). N-terminal of the coiled-coil-domain matrilin-2 carries a
unique domain and at the N-terminus matrilin-2 and -3 have short
sequences with a clustering of positively charged side chains.
Matrilins act as adaptor proteins in the extracellular matrix and
this function can be modulated by structural heterogeneity. Alter-
native splicing, the formation of homo- and heteroligomers and
proteolytic processing lead to variability in subunit and domain
composition and can decrease or increase the binding avidity.
Matrilins interact with a variety of extracellular matrix proteins
such as aggrecan, collagen I, II and IX, cartilage oligomeric matrix
protein (COMP) and the small leucine rich repeat proteoglycans
decorin and biglycan [2–8]. Genetic deletion of matrilin-1 and -3
in mouse leads to moderate changes in cartilage collagen ﬁbril vol-
ume density [9]. Mutations in matrilins, especially in matrilin-3,
are associated with various skeletal diseases, e.g. multiple epiphy-
seal dysplasia (MED), bilateral hereditary micro-epiphyseal dyspla-
sia, spondylo-epi-metaphyseal dysplasia, and osteoarthritis [10–
13]. Most of the mutations in matrilin-3 that cause MED are
located in the b-sheet of the VWA domain [14] and often lead to
retention of matrilin-3 in the endoplasmic reticulum (ER) resulting
in ER-stress response [15–18]. However, other mutations were
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affects the collagen ﬁbril organization [8].
The interactions of matrilins with other proteins are mediated
by their VWA domains. VWA domains are modules of about 200
amino acids which are present in a large number of intra- and
extracellular proteins [19]. VWA domains show a classical Ross-
mann-fold [20] with a central b-sheet and surrounding amphi-
pathic a-helices. In many VWA domains a well-conserved metal
ion dependent adhesion site (MIDAS) motif is involved in ligand
binding [21]. The MIDAS motif is composed of ﬁve amino acid res-
idues (DXSXSXnTXnD) present in three different loops at the C-ter-
minal end of the b-sheet, the top face of the domain. Many VWA
domains, e.g. the matrilin-3 VWA domain, contain an imperfect
MIDAS motif where single residues are substituted by similar
amino acids. The N- and C-termini are in close proximity at the
bottom face of the domain where the structure is often stabilized
by a disulﬁde bridge formed by the two terminal cysteine residues.
An exception is the collagen VI a3N5 domain that has N- and C-ter-
mini at opposite sides of the domain [22].
The structures of several VWA domains have been solved, with
the best characterized being the integrin I domains and the com-
plement factor VWA domains (for review see [23]). The VWA
domains of collagens and matrilins form two neighboring phyloge-
netic subbranches [24], but no VWA domain structure of the matri-
lin subbranch is known. The identity between the VWA domains of
matrilins is highest between matrilin-1 VWA1 and matrilin-3
VWA1 (62.6%) and lowest between matrilin-1 VWA1 and matri-
lin-2 VWA2, as well as between matrilin-4 VWA1 and matrilin-4
VWA2 or matrilin-1 VWA2 (all 37.2%). The identity between matri-
lin VWA domains and the previously structurally characterized
homologs is lower and only the identities between the matrilin-1
VWA2 domain and the VWA domain (I-domain) of the a subunit
of integrin a1b1 (31.4%) and between the matrilin-2 VWA1 the
N5 domain of the collagen VI a3 chain (30.1%) is higher than
30%. The recombinant expression of single matrilin VWA domains
in eukaryotic cells has been described [5–7]. However, in this study
we took a comprehensive approach to the recombinant expression
of functional VWA domains of all matrilins to enable studies of
structure and interactions by X-ray crystallography and nuclear
magnetic resonance (NMR). The focus was on expression in Esche-
richia coli as this would allow the incorporation of isotope-labeled
amino acids, needed for NMR studies, and was expected to give
high protein yields. However, we found that bacterially expressed
matrilin VWA domains, unlike VWA domains from some other pro-
teins, differ in their solubility and functional properties from such
domains expressed in eukaryotic cells.Materials and methods
Protein expression and puriﬁcation
All constructs were generated by PCR using the primers listed in
Supplemental Table 1. The primers introduced sequences for
restriction sites that were used for digestion of the PCR product
and subsequent ligation into a modiﬁed pET 15b expression vector
(Novagen) for expression in E. coli or a modiﬁed pCEP-Pu-vector
[25] for expression in human 293EBNA cells. Both vectors contain
an N-terminal One-STrEP-tag. The pCEP-Pu-vector in addition car-
ries a BM40 signal sequence to allow secretion of the recombinant
protein. For the expression of a codon-optimized VWA domain the
vector pJexpress (DNA2.0) was used. Constructs encoding fusion
proteins with the B1 domain from streptococcal protein G and with
the chaperone SlyD were generated by inserting the PCR-fragment
into the vector GEV2 [26] or a modiﬁed SlyD fusion expression vec-
tor [27].The matrilin constructs for bacterial expression were used for
transformation of E. coli BL21 Rosetta™ cells (Novagen). Single col-
onies were cultured overnight at 37 C in 10 ml LB-medium and
50 lg/ml ampicillin for selection. One liter LB-medium (or M9-
minimal medium containing 15N-ammonium chloride and 13C-glu-
cose for isotope labeling) was inoculated with the overnight cul-
ture. The cultures were grown with a ﬂask shaking rate of
220 rpm in the presence of 50 lg/ml ampicillin to A600 = 0.40.6
at 37 C. After adding isopropyl-b-D-1-thiogalactopyranoside
(IPTG) to a ﬁnal concentration of 1 mM, the cultures were incu-
bated overnight at 28 C. The harvested cells were then resus-
pended in 50 ml of the buffer needed for subsequent
experiments and lysed by sonication. After centrifugation at
15,000 rpm for 20 min, the supernatant was used for afﬁnity
puriﬁcation.
The construct for eukaryotic expression was used for transfec-
tion of human 293EBNA cells (Invitrogen) using the FuGENE HD
transfection reagent (Promega) according to the manufacturer’s
instructions. 293EBNA cells transfected with constructs encoding
COMP T3 + TC domains [5] or the decorin core protein lacking its
glycosaminoglycan attachment site in a His-tag containing vector
were kindly provided by Frank Zaucke. Transfected cells were
selected with puromycin (0.5 lg/ml). Cells were cultured in
DMEM/F-12 + GlutaMAX-I cell culture medium (Gibco) containing
10% (v/v) fetal calf serum (FCS).
Bacterial supernatant or cell culture medium was applied to a
StrepTactin column (IBA). Subsequently the column was washed
with buffer containing the appropriate additives (see Table 2).
10 mM Tris–HCl, 150 mMNaCl, pH 7.4, or 20 mM Hepes,
150 mM NaCl, 2 mM MgCl2, pH 7.4, was used when the protein
was expressed for circular dichroism spectroscopy or surface plas-
mon resonance experiments, respectively. For NMR experiments
50 mM KH2PO4/K2HPO4, 150 mM NaCl, pH 7.4, was used or, when
a lower conductivity was needed, 20 mM Bis–Tris, 150 mM KCl, pH
7.0. For elution of the recombinant protein 2.5 mM desthiobiotin
was added to the washing buffer. His-tag containing proteins were
loaded on a TALON metal afﬁnity resin column (Clontech), washed
with Tris buffered saline (TBS) and eluted with a serial dilution of
imidazole in TBS (5–300 mM).
Protein solubility testing
To test protein solubility, buffer additives were introduced in
the washing and elution buffer during the afﬁnity puriﬁcation of
the matrilin-4 VWA2 domain. After elution, the protein was stored
overnight at 4 C, 23 C or 37 C and time was measured until the
protein visibly precipitated. If the protein did not precipitate over-
night, it was concentrated using an Amicon Ultra-4 Centrifugal Fil-
ter Unit (Millipore) to 2–10 mg/ml. Subsequently, time was
measured until visible protein precipitation occurred. An increase
in solubility was noted if the time until precipitation increased.
SDS–polyacrylamide gel electrophoresis
Afﬁnity-puriﬁed proteins were subjected to SDS–polyacryl-
amide gel electrophoresis on a 15% (w/v) polyacrylamide gel and
stained with colloidal Coomassie staining solution [28].
Mass spectrometry
The MALDI-TOF measurement was carried out by the Central
Bioanalytic Core Unit in the Center for Molecular Medicine
Cologne, University of Cologne. The protein was desalted on a C4
Zip Tip (Millipore) and measured in Super DHB (a mixture of 2,5-
dihydroxybenzoic acid (2,5-DHB) and 2-hydroxy-5-methoxyben-
zoic acid) at a mass range of 10–80 kDa.
Table 1
List of experiments performed with bacterially expressed proteins.
VWA domain construct Performed experiments
Matrilin-1 VWA1a Solubility testing
Matrilin-1 VWA2a Solubility testing, CD
Matrilin-2 VWA1a Solubility testing, CD
Matrilin-2 VWA2a Solubility testing
Matrilin-3 VWAa Solubility testing, CD, NMR
Matrilin-4 VWA1a Solubility testing, CD
Matrilin-4 VWA2a Solubility testing, CD, SPR,
NMR, X-ray crystallography
Matrilin-4 VWA2a without
cysteine residues
Solubility testing
Matrilin-4 VWA2a fused to SlyD Solubility testing
Matrilin-4 VWA2a fused to B1
domain of streptococcal protein G
Solubility testing
Matrilin-3a VWAb Solubility testing
Matrilin-4 VWA1b Solubility testing
Matrilin-4 VWA2b Solubility testing, CD, NMR,
X-ray crystallography
a Mouse.
b Zebraﬁsh.
Fig. 1. Puriﬁed murine matrilin VWA domains expressed in E. coli. After expression,
the VWA domains were afﬁnity puriﬁed via a One-STrEP-tag. The elution fraction
was subjected to electrophoresis on a SDS–polyacrylamide gel (15%) and stained
with Coomassie. Matrilin-1 VWA1 and matrilin-2 VWA2 could not be expressed in
sufﬁcient amounts.
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Circular dichroism spectra were recorded in a Jasco J-715 spec-
tropolarimeter using a thermostated 1 mm path length quartz cell
(Hellma). Proteins were dissolved in 10 mM Tris, 150 mM NaCl, pH
7.4, at a concentration of 0.2 mg/ml. Far-ultraviolet spectra (180–
250 nm) were recorded at 20 C. The buffer background was sub-
tracted and the data converted to mean molar residue ellipticity.
Surface plasmon resonance spectroscopy
All measurements were performed on a BIAcore 2000 instru-
ment at 25 C. COMP T3 + TC and the decorin core protein were
immobilized on a CM5 chip. The chip surface was activated by a
1:1 mixture of 100 mM N-hydroxysuccinimide (NHS) and
400 mM 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC).
Immobilization was carried out at a ﬂow rate of 5 ll/min for
20 min in 25 mM sodium acetate, pH 4.5, or pH 5.0. The remainingTable 2
Buffer additives, temperature conditions and constructs used in attempts to
Buffer additives 50 mM Arginine + glutamic acid
binding partner COMP T3 + TC (molar ratio
5 mM Iodoacetamide
0.06% Polyethylene glycol (PEG)-400 und P
1 mM N-ethylmaleimide
0.5 M Trehalose
2 M Urea
5 mM CHAPS
0.5% Citraconic acid anhydride
1% Cyclodextrin
0.5 M and 1 M NDSB-256
5 mM and 10 mM Dithiothreitol
10% Glycerol
0.5 M Lactose
0.1% and 1% Octyl glucoside
1.5 M Sorbitol
Temperature Puriﬁcation at 4 C
Puriﬁcation at 23 C
Puriﬁcation at 37 C
Heat shock at 42 C (prior to adding IPTG)
Constructs Matrilin-4 VWA2 without cysteines
Fusion protein with the chaperone SlyD
Fusion protein with the B1 domain of the
streptococcal protein G
+ = protein solubility increased,  = protein solubility not increased, iFOLDfree NHS esters were inactivated with 1 M ethanolamine–HCl, pH
8.5. Non-bound proteins were removed with 2 M NaCl in 25 mM
sodium acetate, pH 5.0. For kinetic measurements the analyte
was passed over the chip surface in a serial dilution in running buf-
fer (10–3000 nM). The analyte was injected at a ﬂow rate of 30 ll/
min with an association period of 300 s and a dissociation period of
500 s. Remaining bound proteins were removed with 2 M NaCl in
running buffer. The baseline resulting from passing the analyte
through a blank ﬂow cell was subtracted from the experimental
data.Nuclear magnetic resonance
A 15N 13C labeled 100 lM mouse matrilin-4 VWA2 domain was
prepared in in 20 mM Bis–Tris, 150 mM KCl, 1 mM NEM, pH 7 and
a 15N 13C labeled 300 lM zebraﬁsh matrilin-4 VWA2 domain was
prepared in 20 mM Bis–Tris, 150 mM KCl, pH 7, respectively.
NMR experiments with the murine domain were performed at
25 C on a Varian Inova 600 MHz (1H) instrument equipped with
a z-gradient triple resonance room temperature probe. 2D
1H–15N and 1H–13C HSQC spectra incorporating gradient enhanced
coherence selection and water ﬂip back were recorded with acqui-
sition times of 63 ms (t1, 15N) and 64 ms (t2, NH) and 16 ms (t1, 13C)increase the solubility of the matrilin-4 VWA2 domain.
[37] +
1:1) [31] +
+
EG-4000 [31] +
+
[38] +
[39] +
[31] 

iFOLD 
iFOLD 
[31] 
[40] 
[31] 
[31] 
iFOLD 





[27] 
[26] Protein in inclusion bodies
= iFOLD Protein Refolding System 2 (Novagen).
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implemented in BioPack (Varian, Palo Alto, US). NMR-experiments
with the zebraﬁsh VWA domain were performed at the Medical
Research Council in Mill Hill (London, UK) at a Bruker Avance
700 MHz (1H) instrument equipped with a z-gradient cryoprobe.
2D 1H–15N HSQS spectra were recorded with acquisition times
104 ms (1H) and 47 ms (15N).
Data were processed using water suppression and mild resolu-
tion enhancement using NMRPipe [29] and were analyzed with
NMRView [30].Results
Expression and stability testing of matrilin VWA domains
To be able to study structure and interactions of the matrilin
VWA domains, we systematically optimized the recombinant
expression of these. For use with methods that require high protein
concentrations or isotope labeling, e.g. X-ray crystallography and
nuclear magnetic resonance (NMR), the proteins were expressed
in a bacterial system (Table 1). Constructs encoding all murine
matrilin VWA domains were expressed in E. coli Rosetta™ cells.
After cultivation, VWA domain expressing cells were resuspended
in the required buffer and sonicated. After centrifugation, the
supernatant was used for afﬁnity puriﬁcation of the VWA domain
via a One-STrEP-tag (Fig. 1). However, bacterially expressed and
puriﬁed matrilin VWA domains always precipitated when the pro-
tein concentration was raised to 2 mg/ml or higher. The highest
solubility was achieved for the matrilin-3 VWA1 and the matrilin
4 VWA2 domain.
To increase solubility, buffer additives were tested by introduc-
ing these in the washing and elution buffers during the afﬁnity
puriﬁcation of the matrilin-4 VWA2 domain, chosen as a prototype
for solubility testing. The agents used were detergents (e.g. CHAPS
and octyl glucoside), osmolytes (e.g. amino acids, polyols and sug-
ars) and alkylating agents (NEM and iodoacetamide) (overview see
[31]). Some of these additives increased the solubility of the matri-
lin-4 VWA2 domain while others did not (Table 2). The highest sol-
ubility was achieved after adding 1 mM N-ethylmaleimide (NEM).
However, even in the presence of solubility increasing additivesFig. 2. Analysis of disulﬁde bonding of the matrilin-4 VWA2 domain expressed in E. coli
SDS–polyacrylamide gel with and without prior reduction with b-mercaptoethanol. (B) M
NEM or 1 mM NEM and 10 mM DTT, respectively. After visible protein precipitation in
SDS–PAGE without reduction on a 15% polyacrylamide gel and stained with Coomassie.the VWA domain eventually precipitated, although at a later time
point.
To determine if temperature inﬂuences the solubility, the
matrilin-4 VWA2 domain was puriﬁed and stored at different tem-
peratures (Table 2). Puriﬁcation and storage at 4 C or at 37 C did
not improve the solubility compared to room temperature. A heat
shock was applied for 30 min prior to induction of protein expres-
sion to release chaperones that should facilitate folding. However,
the solubility of the matrilin-4 VWA2 domain was not increased. A
fusion protein of the matrilin-4 VWA2 domain and the chaperone
SlyD was generated to facilitate proper folding of the domain and
thereby decreasing aggregation [27]. This fusion protein was how-
ever only poorly expressed. A second fusion protein that connects
matrilin-4 VWA2 to the B1 domain of the streptococcal protein G
[26] to increase solubility yielded more protein in inclusion bodies.
All matrilin VWA domains contain two cysteine residues that
may form disulﬁde bonds to stabilize the structure. Such proteins
often migrate differently on SDS-polyacrylamide gels under reduc-
ing and non-reducing conditions. However, the matrilin-4 VWA2
domain expressed in E. coli showed similar migration under both
conditions (Fig. 2A). The disulﬁde bonds may not be correctly
formed during protein expression in bacteria. To test this possibil-
ity, precipitated material was subjected to SDS–polyacrylamide gel
electrophoresis under non-reducing conditions (Fig. 2B). A pattern
with many bands representing higher aggregates was obtained.
The presence of NEM or DTT in the buffer used for puriﬁcation
markedly decreased the proportion of aggregates. Remaining solu-
ble material gave a single band representing the monomeric
domain. To eliminate all disulﬁde exchange, a construct was gener-
ated for expression of a matrilin-4 VWA2 domain that lacks the
ﬂanking cysteine residues. However, the resulting protein showed
an increased tendency for aggregation and precipitation. Thus, the
cysteine residues are necessary for protein stability, while disulﬁde
bond exchange enhances protein aggregation which also leads to
precipitation.
The matrilin VWA domains showed decreased solubility in the
presence of EDTA. Divalent cations may bind to the MIDAS motif
and cause a conformational change of the VWA domain that favors
solubility. To test for divalent cation binding, 1H–15N-HSCQ- and
1H–13C-HSCQ-spectra were recorded of a 15N–13C-labeled matri-
lin-4 VWA2 domain in the presence of EDTA or Mg2+ (Fig. 3). Both. (A) The matrilin-4 VWA2 domain was subjected to electrophoresis on a 15% (w/v)
atrilin-4 VWA2 was puriﬁed without buffer additives and in the presence of 1 mM
the elution fractions, precipitated and remaining soluble protein were subjected to
Left: molecular mass marker in kDa.
Fig. 3. Comparison of the solution structures of bacterially expressed mouse
matrilin-4 VWA2 domain in the presence of Mg2+ or EDTA by high resolution NMR.
1H–15N-HSQC-spectra (A) and 1H–13C-HSQC-spectra (B) of the 15N–13C-labeled
mouse matrilin-4 VWA2 domain ((100 lM, 20 mM Bis–Tris, 150 mM KCl 1 mM
NEM, at pH = 7 and at a temperature of 25 C)) were recorded after adding 2 mM
MgCl2 (black) or 2 mM EDTA (red), respectively. Chemical shift differences in the
spectra are highlighted with green circles. (For interpretation of the references to
color in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 4. Puriﬁcation of the bacterially expressed zebraﬁsh matrilin-4 VWA2 domain.
The matrilin-4 VWA2 domain was afﬁnity puriﬁed via a One-STrEP-tag. Bacterial
lysate (L), ﬂow through (F), washing fraction (W) and the ﬁrst four elution fractions
(1–4) were subjected to a SDS–polyacrylamide gel (15%) without reduction and
stained with Coomassie. Left: molecular mass marker in kDa.
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protein. Most of the resonances remained in the same position in
both conditions with only a small number of peaks that were
exclusively seen in one of the two conditions. This indicates the
overall structure of the protein stays the same and that Mg2+ bind-
ing only causes a local structural perturbation. It was also noted
that overall the peak intensities in the presence of EDTA are some-
what lower leading to an apparent loss of resonances at the chosen
plotting threshold in Fig. 3. There are a number of possible contrib-
uting factors such as enhanced aggregation or line broadening due
to increased internal ls-ms dynamics of the protein in the pres-
ence of EDTA. Also the addition of EDTA triggered a slight protein
precipitation during the NMR measurement. Both effects are con-
sistent with a less stable protein in the absence of Mg2+ indicating
that divalent cations can stabilize the structure of this VWA
domain.Comparison of different matrilin VWA domains
In addition to the murine matrilin VWA domains the zebraﬁsh
matrilin-3a and matrilin-4 VWA domains were expressed in E. coli.
Interestingly, the highest protein solubility among all matrilin
VWA domains expressed in bacteria was obtained for a matrilin-
4 VWA2 domain from zebraﬁsh. This domain could be concen-
trated to 10 mg/ml without visible protein precipitation. A
codon-optimized version (DNA2.0) of the zebraﬁsh matrilin-4
VWA2 domain was afﬁnity puriﬁed from E. coli supernatants by
use of a One-STrEP-tag (Fig. 4). The protein was mainly in the
monomeric form and only slight amounts of dimers and higher
aggregates were detected. A high resolution 1H–15N HSQC spec-
trum of the 15N–13C labeled domain was recorded to assess the
folding state (Fig. 5). The spectrum is well dispersed and has line-
shapes consistent with the size of a monomeric protein sample.
Discounting NH2 resonances arising from side chains, approxi-
mately 180 NH resonances could be observed. While this is broadly
consistent with the number of signals expected for this construct
there are still in the order of 10% of signals missing, suggesting that
there are some regions of the protein that have broad lineshapes
potentially due to rapid solvent exchange or ls–ms time scale
dynamics. Overall the spectrum suggests that this domain is
folded. However, collection of triple resonance data for backbone
assignments was impeded by the limited lifetime at the required
sample concentrations for these experiments. The zebraﬁsh matri-
lin-4 VWA2 domain was also used for crystallization attempts, but
the structure could not be determined due to lacking
crystallization.
To determine if bacterially expressed murine matrilin VWA
domains have similar properties as eukaryotically expressed
domains, all such domains were also expressed in human 293EBNA
cells (Fig. 6). All these VWA domains were better soluble than the
corresponding bacterially expressed proteins. For example, at
2 mg/ml the eukaryotically expressed murine matrilin-4 VWA2
domain remained in solution whereas the murine protein
expressed in E. coli precipitated. A proper formation of the disulﬁde
bond in the protein expressed in human cells is indicated by a
mobility shift in SDS–polyacrylamide gels after reduction (Fig. 7)
that is in contrast to the VWA domain expressed in E. coli.Comparison of folding and interactions of matrilin VWA domains
expressed in E. coli and eukaryotes
To determine if the bacterially expressed matrilin VWA
domains were properly folded, circular dichroism (CD) measure-
Fig. 5. Solution structure of the bacterially expressed zebraﬁsh matrilin-4 VWA2 domain. 1H–15N HSQC spectrum of bacterially expressed zebraﬁsh matrilin-4 VWA2 domain
from zebraﬁsh (M4zA2) recorded at 25 C in 20 mM Bis–Tris, 150 KCl, pH 7, at 600 MHz. The spectrum is well dispersed and shows approximately the correct number of NH
peaks indicating a well-folded and structurally homogeneous protein construct.
Fig. 6. Puriﬁed murine matrilin VWA domains expressed in 293EBNA cells. After expression, the VWA domains were afﬁnity puriﬁed via a One-STrEP-tag and subjected to
electrophoresis on a SDS-polyacrylamide gel (15%) and stained with Coomassie.
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VWA2 could not be puriﬁed in sufﬁcient amounts. All other matri-
lin VWA domains showed far-UV spectra that are consistent with
that of a typical Rossmann fold [32] with minima at 209 and
222 nm. Thus, the bacterially expressed protein domains contain
the secondary structure elements present in a Rossmann fold.
Together with the well-dispersed NMR spectra of the matrilin-4
VWA2 domain shown above (Fig. 3) the data suggest that the bac-
terially expressed domains overall have the correct three dimen-
sional structure. Direct comparison of the CD-spectra of matrilin-
4 VWA2 domains expressed either in E. coli or in human 293EBNA
cells showed a great similarity (Fig. 8B). Thus, the bacterially
expressed matrilin VWA domains adopt a native like structure.The matrilin-4 VWA2 domain was investigated more closely by
comparing the binding properties of bacterially and eukaryotically
expressed constructs to COMP [5,6] and decorin [5,33], two well
characterized binding partners of matrilins. Surface plasmon reso-
nance measurements were performed using COMP T3 + TC, repre-
senting the matrilin binding domains of COMP [5], and the decorin
core protein as ligands (Fig. 9). While the matrilin-4 VWA2 domain
expressed in 293EBNA cells strongly interacted with both binding
partners, the VWA domain expressed in E. coli showed much
weaker binding.
It can be excluded that glycosylation, only present on a eukary-
otic protein, is necessary for the binding. Mass spectrometry
(MALDI-TOF) showed that the measured mass (21121.0m/z) was
Fig. 7. Analysis of the disulﬁde bond present in matrilin-4 VWA2 domain expressed
in human 293EBNA cells. The matrilin-4 VWA2 domain was afﬁnity-puriﬁed via a
One-STrEP-tag and subjected to electrophoresis on a 15% (w/v) SDS–polyacrylamide
gel with and without prior reduction with b-mercaptoethanol. Proteins were
stained with Coomassie. Left: molecular mass marker in kDa.
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ﬁed VWA domain.Discussion
Disulﬁde exchange leads to stability problems after expression in E. coli
Matrilin VWA domains were initially expressed in bacteria as
several successfully crystallized VWA domains from other proteins
have earlier been expressed in E. coli. This is a cost-effective sys-
tem, which yields large amounts of protein in a short time and
allows isotope labeling. However, bacterially expressed matrilin
VWA domains showed a stronger tendency to aggregation and a
lower solubility, although CD and NMR spectroscopy indicated that
they were appropriately folded. For structure determination by
either X-ray crystallography or NMR protein concentrations of sev-
eral mg/ml are needed. This could not overcome by using a number
of stabilizing buffer additives, as the bacterially expressed matrilin
VWA domains were not stable in solution. Furthermore, engineer-Fig. 8. Analysis of the folding of bacterially expressed matrilin VWA domains by circu
matrilin-1 VWA2 (orange), matrilin-2 VWA1 (red), matrilin-3 (green), matrilin-4 VWA1 (
fold occurring in VWA domains. (B) The spectra of bacterially (blue) und eukaryotically
content of different secondary structure elements. (For interpretation of the references toing solubility enhancing tags onto the proteins designed did not
yield stable solutions of matrilin VWA domains.
All matrilin VWA domains expressed in human cells showed an
increased stability compared to the same protein domains
expressed in E. coli. The eukaryotic expression of recombinant
extracellular proteins allows representative posttranslational mod-
iﬁcations, such as glycosylation and it has indeed been shown that
the presence of glycan chains on the VWA domains of matrilin-1
affects their structure and thermal stability [7]. However, this does
not explain the better solubility of the eukaryotically expressed
matrilin-4 VWA2 domain that was characterized in this study, as
it does not carry such modiﬁcations. Nevertheless, in a functional
assay only the eukaryotically expressed VWA domains interacted
strongly with their physiological binding partners, whereas the
bacterially expressed domains displayed much weaker binding.
The problems encountered when expressing this domain in bacte-
ria probably arose from incorrectly formed disulﬁde bonds. In sev-
eral VWA domains disulﬁde bonds serve to stabilize the structure
[15], but the matrilin-4 VWA2 domain was shown to form insolu-
ble aggregates due to disulﬁde exchange. The extent of shufﬂing
could be decreased by the addition of alkylating agents like N-eth-
ylmaleimide or iodoacetamide. However, even with these additives
stable protein solutions could not be obtained. Eukaryotic expres-
sion allowed a correct formation of disulﬁde bonds indicated by a
mobility shift in SDS–polyacrylamide gels after reduction and
yielded protein solutions that were stable for several weeks. Both
eukaryotic and bacterial cells have reducing conditions in their
cytoplasm, but eukaryotic cells allow the formation of disulﬁde
bonds under oxidative conditions in the ER. As bacterial cells lack
this compartment, recombinant proteins with disulﬁde bonds in
their native structure are often misfolded [34]. With the exception
of the VWA domains of the anthrax toxin receptor and the von
Willebrand factor A1 and A3 domains, those VWA domains that
were previously expressed in bacteria and crystallized carried no
terminal cysteine residues or contained either no cysteine residue
or a single one in the middle of the protein sequence. In contrast,
all matrilin VWA domains contain cysteine residues at the C- and
N-terminus, which most likely form an intramolecular disulﬁde
bond. A construct of the matrilin-4 VWA2 domain that lacks the
terminal cysteine residues showed a strong tendency to aggrega-lar dichroism spectroscopy. (A) Far-UV CD spectroscopy of bacterially expressed
light blue) and matrilin-4 VWA2 (dark blue) shows spectra typical for the Rossmann
(pink) expressed matrilin-4 VWA2 domain are closely similar indicating the same
color in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 9. Binding of bacterially and eukaryotically expressed matrilin-4 VWA2 to COMP T3 + TC and decorin core protein as measured by surface plasmon resonance. The
eukaryotically expressed matrilin-4 VWA2 domain binds in a concentration dependent manner to the immobilized COMP T3 + TC domains (A) and to the immobilized decorin
core protein (B). The binding of the bacterially expressed domain to both ligands was markedly reduced (C and D). Matrilin-4 VWA2 was used as an analyte in a serial dilution
(10 nM, 30 nM, 100 nM, 300 nM, 1000 nM, 3000 nM). RU = resonance units.
A.-K.A. Becker et al. / Protein Expression and Puriﬁcation 107 (2015) 20–28 27tion. Thus, the disulﬁde bond is important for stabilization of the
fold. Hence, the data suggest that structural studies of matrilin
VWA domains would beneﬁt from an eukaryotic expression sys-
tem. Still crystallization attempts with the eukaryotically
expressed matrilin-4 VWA2 and matrilin-3 VWA domains were
not yet successful (data not shown) indicating that correct disul-
ﬁde bond formation may not be sufﬁcient for crystal formation
and may be a result of an intrinsic tendency of these domains to
aggregate. Unspeciﬁc ‘‘stickiness’’ seems to be more pronounced
for matrilin VWA domains than for other VWA domains. In elec-
tron microscopy the VWA domains of matrilin-1 and -2 show a
self-interaction [35,36]. This may well be a result of the role of
the matrilins as adaptor proteins in the extracellular matrix and
the fact that their VWA domains provide the sites of interaction.
Aggregation of matrilin VWA domains may be physiologically rel-
evant and could contribute to the supramolecular assembly of
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